NCT06440044Completed
Recurrence and Bleeding in Colorectal Cancer Patients With Cancer-associated Venous Thrombembolism
Source: ClinicalTrials.gov · Last updated 15 Jul 2024
Brief summary (registry, in English)
Patients with colorectal cancer (CRC) have a higher risk of both venous thromboembolism (VTE) and major bleeding (MB). Patients with CRC are underrepresented in the major trials examining treatment of cancer-associated VTE with anticoagulant.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 2000 (actual)
- First submitted
- 28 May 2024
- Start date
- 1 Jan 2019
- Primary completion date
- 16 Jun 2024
- Lead sponsor
- Sixth Affiliated Hospital, Sun Yat-sen University
- Diseases
- Colorectal cancer
- NCT number
- NCT06440044
What you commit to
- Study type: Observational
- Participants enrolled: 2000
- From 1 Jan 2019 to the primary completion date, 16 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- 1\. Participation in this study required active anticoagulant treatment. Apart from this, there were no specific exclusion criteria.
Who the study is looking for
- Patients with histologically confirmed CRC and symptomatic or incidental VTE who received anticoagulant treatment.
- CRC patients with VTE treated with an anticoagulant (rivaroxaban or LMWH) for at least six months.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Sixth Affiliated Hospital of Sun Yat-sen University Coordinator of this site? Confirm its status | Guangzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.